Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (3071)	5/27/1999 4:29:00 PM
From: David Howe	Read Replies (1) of 10280

>>If SEPR were to have no blockbusters, then the current discount to a Forest Labs or a Mylan should be even larger<< Sepracor could potentially have 20 blockbusters. (Blockbuster being a relative term for a company of this size) 1 blockbuster brought to market on their own could drive the stock to 200 per share. Typically a pharma company goes for around 10 x sales. If they get a drug to market on their own that sells $1 billion per year, the market cap could be around $10 billion. That would put SEPR at about $240 per share. SEPR's current pipeline has sales of the parent drugs of around $14 billion. Just a thought. Dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next